The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitroand in vivo studies

The radiolabeling of the natural octapeptide CCK8, derivatized with a cysteine residue (Cys-Gly-CCK8), by using the metal fragment [99mTc(N)(PNP3)]2+ (PNP3 = N,N-bis(dimethoxypropylphosphinoethyl)methoxyethylamine) is reported. The [99mTc(N)(NS-Cys-Gly-CCK8)(PNP3)]+ complex was obtained according to two methods (one-step or two-step procedure) that gave the desired compound in high yield. The complex is stable in aqueous solution and in phosphate buffer. In vitro challenge experiments with an excess of cysteine and glutathione indicate that no transchelation reactions occur, confirming the high thermodynamic stability and kinetic inertness of this compound. Stability studies carried out in human and mouse serum, as well as in mouse liver homogenates, show that the radiolabeled compound remains intact for prolonged incubation at 37 degrees C. Binding properties give Kd (19.0 +/- 4.6 nmol/l) and Bmax (approximately 10(6) sites/cell) values in A431 cells overexpressing the CCK2-R. In vivo evaluation of the compound shows rapid and specific targeting to CCK2-R, a fourfold higher accumulation compared to nonreceptor expressing tumors

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia

BACKGROUND: Glycogen storage disease type 1a (GSD Ia) is characterized by severe fasting hypoglycemia. The clinical management includes the administration of uncooked cornstarch (UCCS). Although such a diet approach is effective in achieving euglycemia, its impact on the quality of life of patients should be considered. In vitro analyses suggest a longer release of glucose when using sweet manioc starch (SMS). METHODS: We compared the efficacy and safety of the administration of SMS and UCCS during a short-fasting challenge in patients with GSD Ia in a randomized, triple-blind, phase I/II, cross-over study. GSD Ia patients aged ≥ 16 years and treated with UCCS were enrolled. Participants were hospitalized for two consecutive nights, receiving UCCS or SMS in each night. After the administration of the starches, glucose, lactate and insulin levels were measured in 1-h interval throughout the hospitalization period. The procedures were interrupted after 10 h of fasting or in a hypoglycemic episode ( 25 kg/m(2)) participated in the study. The average fasting period was 8.2 ± 2.0 h for SMS and 7.7 ± 2.3 h for UCCS (p = 0.04). SMS maintained euglycemia for a greater period over UCCS. Increased lactate concentrations were detected even in absence of hypoglycemia, not being influenced by the different starches investigated (p = 0.17). No significant difference was found in total cholesterol, HDL, triglycerides and uric acid levels in both arms. None of the patients showed severe adverse events. CONCLUSIONS: SMS appears to be non-inferior to UCCS in the maintenance of euglycemia, thus emerging as a promising alternative to the treatment of GSD Ia

Actualidad de la capacitación en Inteligencia de Negocios brindada por organizaciones latinoamericanas

En la actualidad no se ha identificado un programa de capacitación que defina con claridad las estrategias didácticas y pedagógicas adecuadas para la formación de usuarios finales de soluciones de Inteligencia de Negocios (BI) en al ámbito de organizaciones en BI en Latinoamérica, e identifica un conjunto de características de las alternativas de capacitación ofrecidas, con el objetivo de permitir la generación de planes de capacitación adecuados para la realización de las organizaciones regionales.Currently, there is no training program that cleary defines the appropiate teaching strategies for teaching end users of BI solutions in the province of Misiones (Argentina). This paper presents a survey about BI training offer at Latinoamérica, and identifies a set of characteristics of the alternatives that offered training, which allow to generate adequate training plans for the reality of regional organizations.Facultad de Informátic

A new phase of bis[2-(diphenylphosphino-\u3baP)phenylazanido-\u3baN](ethanolato)(oxo)rhenium(V)

The title compound, [Re(C18H15NP)2(C2H5O)O], was synthesized by the oxidation-substitution reaction of [Re(III)(PNH)2(PNH2)]Cl, where PNH2 is 2-(diphenylphosphino)phenylamine, with NEt3 in EtOH. The X-ray diffraction study of this new triclinic phase, designated beta, confirms the molecular structural details for the monoclinic a isomer, which crystallized in space group P2(1)/c with a = 12.056 (3), b = 26.303 (6), c = 11.005 (3) angstrom, beta = 102.32 (2)-degrees [Refosco, Tisato, Bandoli, Bolzati, Dolmella, Moresco & Nicolini (1993). J. Chem. Soc. Dalton Trans. pp. 605-618]

Synthesis and NMR investigation on mer-[Re(III)Cl(3)(L)(3)] and mer-[Re(III)Cl(3)(L)(2)(PPh(3))] complexes (L = pyridine-like ligand). X-ray structure of mer-[Re(III)Cl(3)(3,5-lut)(3)]

The co-ordination geometry of the monomeric rhenium complexes mer-[Re(III)Cl(3)(L)(3)] (L = py 1,3,5-lut 2, 4-pic 3) has been determined in the solid state by single X-ray diffraction of the representative complex 2 and in solution by proton NMR spectroscopy. Only a single stable conformation has been found in the solid state and in solution, under the experimental conditions utilised. The NMR spectra of the related complexes mer-[Re(III)Cl(3)(L)(2)(PPh(3))] (L = py 4, 3,5-lut 5, 4-vinpy 6) have also been reported for comparison purposes. (C) 1998 Elsevier Science Ltd. All rights reserved

Structural overview of technetium compounds (1993-1999)

This paper investigates the structural aspects of technetium-containing complexes. The focus is on the description of the various coordination environments around the technetium center. The complexes are divided according to the coordination sphere and the most significant structural parameters are reviewed and discussed. The review covers the crystallographic determinations published in the years between 1993 and 1999. (C) 2001 Elsevier Science B.V. All rights reserved

Mononuclear six-coordinated Ga(III) complexes: A comprehensive survey

Given the commercial availability of (68)Ge-(68)Ga generators, in principle analogous to the worldwide utilized (99)Mo-(99m)Tc generator, it is surprising that few (68)Ga agents have been developed beyond basic research toward clinical application. The use of the unconventional (68)Ga positron emitter would allow for a cost-effective production of (68)Ga radiotracers far from a cyclotron facility. Moreover, the use of (67)Ga radiopharmaceuticals for imaging studies, and the application of non-radioactive gallium compounds in the treatment of important disorders, including a number of cancer and infectious diseases, make studies on trivalent Ga coordination chemistry attractive for the design of novel gallium-based drugs. The aim of this review is to survey the reported crystal data of six-coordinated Ga(III) complexes in order to gain information to be used in the design of novel Ga complexes of medicinal interes